Second-line treatments, known as device-aided therapies (DATs), have been developed for LDRCs, such as continuous subcutaneous apomorphine infusion (CSAI), continuous subcutaneous foslevodopafoscarbidopa, infusion of levodopacarbidopa intestinal gel (LCIG entacapone) and subthalamic deep brain stimulation
(By contrast, plain sterile water for injection contains no preservative and is meant for single-use only.) Key Features Composition: Bacteriostatic water contains 0.9% (9 mg/mL) benzyl alcohol in USP-grade sterile water
Figure 6D presents serum glutamate levels among different groups (F (5, 12) = 27.42, p 0.05)
BPC-157 + TB-500 BPC-157 + TB-500 Injectable BPC-157 + TB-500 (10mg/10mg) Injectable Category: Inflammation, Repair, & Recovery BPC-157 (Body Protective Compound-157) and TB-500 (Thymosin Beta-4) work synergistically to enhance the bodys natural healing, repair, and recovery processes
It is not for human consumption, veterinary use, or therapeutic application